131 related articles for article (PubMed ID: 22169282)
1. [Comparison of proteomics between acute myeloid leukemia and acute lymphoid leukemia].
Xiao P; Zeng YY; Nie YF; Lin W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1353-6. PubMed ID: 22169282
[TBL] [Abstract][Full Text] [Related]
2. [Proteomics analysis of bone marrow cells of acute myeloid leukemia M2a and prognostic significance thereof].
Tian S; Meng FY; Tang JM
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):538-41. PubMed ID: 17459203
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of childhood leukemia.
Hegedus CM; Gunn L; Skibola CF; Zhang L; Shiao R; Fu S; Dalmasso EA; Metayer C; Dahl GV; Buffler PA; Smith MT
Leukemia; 2005 Oct; 19(10):1713-8. PubMed ID: 16136170
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses.
Braoudaki M; Tzortzatou-Stathopoulou F; Anagnostopoulos AK; Papathanassiou C; Vougas K; Karamolegou K; Tsangaris GT
Amino Acids; 2011 Mar; 40(3):943-51. PubMed ID: 20711619
[TBL] [Abstract][Full Text] [Related]
5. Proteomics strategy based on liquid-phase IEF and 2-D DIGE: application to bone marrow mesenchymal progenitor cells.
Seshi B
Proteomics; 2007 Jun; 7(12):1984-99. PubMed ID: 17516591
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of human acute leukemia cells: insight into their classification.
Cui JW; Wang J; He K; Jin BF; Wang HX; Li W; Kang LH; Hu MR; Li HY; Yu M; Shen BF; Wang GJ; Zhang XM
Clin Cancer Res; 2004 Oct; 10(20):6887-96. PubMed ID: 15501966
[TBL] [Abstract][Full Text] [Related]
7. Differential protein analysis of lymphocytes between children with acute lymphoblastic leukemia and healthy children.
Wang D; Lv YQ; Liu YF; Du XJ; Li B
Leuk Lymphoma; 2013 Feb; 54(2):381-6. PubMed ID: 22812402
[TBL] [Abstract][Full Text] [Related]
8. Construction of protein profile classification model and screening of proteomic signature of acute leukemia.
Xu Y; Zhuo J; Duan Y; Shi B; Chen X; Zhang X; Xiao L; Lou J; Huang R; Zhang Q; Du X; Li M; Wang D; Shi D
Int J Clin Exp Pathol; 2014; 7(9):5569-81. PubMed ID: 25337199
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets.
López-Pedrera C; Villalba JM; Siendones E; Barbarroja N; Gómez-Díaz C; Rodríguez-Ariza A; Buendía P; Torres A; Velasco F
Proteomics; 2006 Apr; 6 Suppl 1():S293-9. PubMed ID: 16521150
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis on multi-drug resistant cells HL-60/DOX of acute myeloblastic leukemia.
Chen CY; Jia JH; Zhang MX; Meng YS; Kong DX; Pan XL; Yu XP
Chin J Physiol; 2005 Sep; 48(3):115-20. PubMed ID: 16304837
[TBL] [Abstract][Full Text] [Related]
11. [Mass spectrography analysis of differential proteome in childhood TEL/AML1-positive acute lymphoblastic leukemia].
Guo Y; Fan BL; Chen YM; Hu Y; Zou Y; Chen XJ; Zhang L; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):116-21. PubMed ID: 20137130
[TBL] [Abstract][Full Text] [Related]
12. [Screen of phosphopeptide specific for acute leukemia].
Peng HL; Dai CW; Zhang GS; Gu TL; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):163-8. PubMed ID: 22781597
[TBL] [Abstract][Full Text] [Related]
13. Screening for methylation-silenced genes in acute myeloid leukemia HL-60 cell line by a quantitative proteomic approach.
Tang C; Tan T; Xiao Y; Ruan L; Li C; Peng F; Li M; Zhang P; Yi H; Xiao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):641-8. PubMed ID: 20693703
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the different proteomes between the acute leukemia cells and normal white blood cells].
Cui JW; Wang GJ; Li W; Wang J; Zhang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):201-7. PubMed ID: 16638180
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
[TBL] [Abstract][Full Text] [Related]
16. [Identification of new markers for childhood acute lymphoblastic leukemia by MALDI-TOF-MS].
Wang D; Lu YQ; Liu YF; Su SF; Li B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1365-9. PubMed ID: 23257434
[TBL] [Abstract][Full Text] [Related]
17. Identification of similarities and differences between myeloid and lymphoid acute leukemias using a gene-gene interaction network.
Chen J; Huang C; Zhu Y; Dong L; Cao W; Sun L; Sun H; Wan D; Liu Y; Zhang Z; Wang C
Pathol Res Pract; 2015 Oct; 211(10):789-96. PubMed ID: 26296916
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].
Zhang XP; Xiao ZQ; Chen ZC; Li C; Li JL; Yu YH; Ouyang YM; Feng XP; Zhang PF
Ai Zheng; 2006 Jan; 25(1):22-8. PubMed ID: 16405744
[TBL] [Abstract][Full Text] [Related]
19. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
20. Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.
Balkhi MY; Trivedi AK; Geletu M; Christopeit M; Bohlander SK; Behre HM; Behre G
Oncogene; 2006 Nov; 25(53):7041-58. PubMed ID: 16732326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
